This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of peptide-based drugs. It serves as a key building block in the preparation of complex molecules, often acting as a precursor for active pharmaceutical ingredients (APIs) targeting neurological and cardiovascular disorders. Its structure, featuring a piperidyl group and a Cbz-protected amine, makes it valuable in medicinal chemistry for designing compounds with enhanced bioavailability and target specificity. Additionally, it is employed in research settings for studying enzyme inhibition and receptor binding mechanisms, contributing to the discovery of novel therapeutic agents.